Abstract
2-[18F]Fluoro-L-tyrosine (2-[18F]FTYR), a labeled fluorinated analog of tyrosine, was prepared using chiral phase-transfer catalysis. The radiochemical yield of 2-[18F]FTYR corrected for radioactive decay was 25±6% (n = 15) at a synthesis time of 110–120 min, including semipreparative HPLC purification. The radiochemical and chemical purity of the product exceeded 99%, and the enantiomeric purity was 98.2±0.7% (n = 15). The uptake of 2-[18F]FTYR by tumors and abscesses in laboratory animals was studied. The ratios of radioactivity uptake by tumor or imflamed tissue to that of an intact muscle tissue were calculated. Within the time of experiment, the tumor/muscle ratio exceeds the abscess/muscle ratio. The results obtained allow 2-[18F]FTYR to be considered as potentially useful radiotracer for differential diagnostics of tumors and inflammations by PET.
Similar content being viewed by others
References
Couturieri, O., Luxen, A., Chatal, J.-F., et al., Eur. J. Nucl. Med. Mol. Imag., 2004, vol. 31, pp. 1182–1206.
Van Waarde, A., Cobben, D.C., Suurmeijer, A.J., et al., J. Nucl. Med., 2004, vol. 45, pp. 695–700.
Wester, H., Herz, M., Weber, W., et al., J. Nucl. Med., 1999, vol. 40, pp. 205–212.
Rau, F.C., Weber, W.A., Wester, W.J., et al., Eur. J. Nucl. Med., 2002, vol. 29, pp. 1039–1046.
Pauleit, D., Stoffels, G., Schaden, W., et al., J. Nucl. Med., 2005, vol. 46, pp. 411–416.
Krasikova, R.N., Zaitsev, V.V., Ametamey, S.M., et al., Nucl. Med. Biol., 2004, vol. 31, pp. 597–603.
Zaitsev, V.V., Fedorova, O.S., Mosevich, I.K., et al., Radiokhimiya, 2002, vol. 44, no. 4, pp. 358–365.
Belokon, Y.N., Kochetkov, K.A., Churkina, T.D., et al., Angew. Chem., Int. Ed., 2001, vol. 40, pp. 1948–1951.
Smrcina, M., Polakova, J., Vyskocyl, S., and Kososky, P., J. Org. Chem., 1993, vol. 58, pp. 4534–4538.
Laverman, P., Boerman, O.C., Corstens, F.H.M., and Oyen, J.G.W., Eur. J. Nucl. Med., 2002, vol. 29, pp. 681–690.
Hamacher, K., Coenen, H.H., and Stocklin, G., J. Nucl. Med., 1986, vol. 27, pp. 235–238.
Heiss, E., Sichler, S., Kluge, A., and Coenen, H.H., Appl. Radiat. Isot., 2002, vol. 57, pp. 185–191.
Hamacher, K. and Coenen, H.H., J. Label. Comp. Radiopharm., 2001, vol. 44,suppl. 1, pp. S855–S856.
Lemaire, C., Damhaut, P., Plenevaux, A., and Comar, D., J. Nucl. Med., 1994, vol. 35, pp. 1996–2002.
Lemaire, C., Gillet, S., Ooi, T., et al., J. Label. Comp. Radiopharm., 2001, vol. 44,suppl. 1, pp. S857–S859.
Hustinx, R., Lemaire, C., and Jerusalem, G., J. Nucl. Med., 2003, vol. 44, pp. 533–539.
Author information
Authors and Affiliations
Additional information
Original Russian Text © O.S. Fedorova, O.F. Kuznetsova, I.K. Mosevich, S.V. Shatik, G.V. Kataeva, Yu.N. Belokon’, R.N. Krasikova, 2006, published in Radiokhimiya, 2006, Vol. 48, No. 5, pp. 458–462.
Rights and permissions
About this article
Cite this article
Fedorova, O.S., Kuznetsova, O.F., Mosevich, I.K. et al. Synthesis of 2-[18F]Fluoro-L-tyrosine and comparative study of its uptake by rat glioma 35 tumor and by induced inflammation focus in experimental animals. Radiochemistry 48, 509–514 (2006). https://doi.org/10.1134/S1066362206050201
Received:
Issue Date:
DOI: https://doi.org/10.1134/S1066362206050201